PubMed COVID-19 Clinical Care

No abstract

SARS-CoV-2 causes COVID-19 pandemic and continues to pose a threat to global public health through genetic mutation. In this study, we have found that an ACE2-specific monoclonal antibody at low concentration was able to enhance SARS-CoV-2 infection

Hemophagocytic lymphohistiocytosis (HLH) is a rare and very dangerous condition characterized by abnormal activation of the immune system, causing hemophagocytosis, inflammation, and potentially widespread organ damage. The primary (genetic) form

In this retrospective cohort study, we investigated the formation of individual classes of antibodies to SARS-CoV-2 in archived serial sera from hospitalized patients with the medium-severe (n = 17) and severe COVID-19 (n = 11). The serum/plasma

CONCLUSION: Random forest and optimized forest models might have significant clinical applications, helping to speed up decision-making when SARS-CoV-2 and RSV are suspected, prior to molecular genome sequencing and/or antigen testing.

Emergency medicine and services have reached a breaking point with the covid-19 pandemic. This pandemic has highlighted the failures of a system that needs to be rethought and novel approaches are to be considered. Artificial Intelligence (AI) has

In this work, a novel sensing structure based on Au nanoparticles/HfO2/fully depleted silicon-on-insulator (AuNPs/HfO2/FDSOI) MOSFET is fabricated. Using such a planar double gate MOSFET, the electrostatic enrichment (ESE) process is proposed for the

No abstract

This study explores international faculty members' resilience and the active challenges to establishing coping mechanisms while facing a mental health crisis provoked by the Delta and Omicron lockdowns in China. Grounded in a qualitative approach

No abstract